Table 1.
Erythropoiesis/ Iron Metabolism |
Cell Survival/ Proliferation |
Angiogenesis | Vascular tone |
Glucose Metabolism |
Matrix Metabolism |
---|---|---|---|---|---|
EPO | IGF2 | VEGF | NOS2 | HK1,2 | MMPs |
Tf | TGF-α | Leptin | HO1 | LDHA | PAR/PAI |
Tfr | ADM | TGF-▯3 | ET1 | PKM | Coll PHD |
Ceruloplasmin | BNip3 | EG-VEGF | ADM | PFKL | |
NIX | α1b | PGK1 | |||
NDRG2 | PFKFB3 | ||||
GAPDH | |||||
GLUT1,3 | |||||
ENO1 | |||||
CA-9 | |||||
ALD-A,C | |||||
AK-3 |
α1b, α1b-adrenergic receptor; ADM, adrenomedulin; AK, adenylate kinase; ALD, aldolase; BNip3, Bcl-2/adenovirus EIB 19kD-interacting protein 3; CA, carbonic anhydrase; Coll PHD, collagen prolylhydroxylases; EG-VEGF, endocrine gland-derived VEGF; ENO, enolase; EPO, erythropoietin; ET, endothelin; GAPDH, gylceraldehyde phosphate dehydrogenase; GLUT, glucose transporters; HK1,2, hexokinase 1,2; HO, heme oxygenase; IGF, insulin-like growth factor; LDH-A, lactate dehydrogenase-A; MMP, matrix metalloproteinases; NDRG, N-Myc downstream-regulated genes; NIX, Nip 3-like protein X; NOS, nitric oxide synthase; PAR/PAI, plasminogen activator receptors and inhibitors; PGK1, phosphoglycerate kinase 1; PFKL, phosphofructokinase L; PKM, pyruvate kinase M; TGF, transforming growth factor; TF, transferrin; Tfr, Tf receptor.